Compare AXT Inc (AXTI) vs Becton Dickinson and Co (BDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AXT Inc vs Becton Dickinson and Co — how do they compare? AXT Inc trades at $78.47 (market cap $4.83B), while Becton Dickinson and Co trades at $181.29 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 10.2× AXT Inc's market cap, and Becton Dickinson and Co pays a 2.32% dividend while AXT Inc pays none. Which is the better fit depends on your goals.
| AXTI | BDX | |
|---|---|---|
Market Cap | $4.83B | $49.41B |
Sector | Technology | Health |
52-Week High | $140.83 | $185.39 |
52-Week Low | $2.05 | $138.62 |
Enterprise Value | $4.50B | $65.51B |
Dividend Yield | — | 2.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →
